ORIGINAL ARTICLES

Preparation and application of monoclonal antibody against Toxoplasma gondii bradyzoite antigen 1

  • ZOU Wei-hao ,
  • WU Wei-ling ,
  • LIAO Yuan-peng ,
  • CHEN Min ,
  • PENG Hong-juan
Expand
  • Department of Pathogen Biology, Guangdong ProvincialKey Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515,China

Received date: 2021-12-20

  Revised date: 2022-01-21

  Online published: 2022-10-17

Supported by

National Natural Science Foundation of China(81971954);National Natural Science Foundation of China(81772217);Science and Technology Planning Project of Guangdong Province(2018A050506038);Key Project of Guangzhou Science Research(201904020011);Basic Research Project of Key Laboratory of Guangzhou(202102100001)

Abstract

Objective To prepare monoclonal antibodies against Toxoplasma gondii bradyzoite antigen 1 (BAG1) and explore its application in identification of T. gondii bradyzoite. Methods The bradyzoites of T. gondii ME49 strain (in vitro induced) after induction in alkaline medium (pH 8.2) for 5 days and the ME49 strain obtained from mouse brain tissue homogenate (in vivo formed) 2 months after chronic infection were collected. Total RNA was extracted from the in vitro induced T. gondii ME49 bradyzoite and amplified by RT-PCR for the bag1 open reading frame segment, which was subcloned into the prokaryotic expression vector pET-28a(+) and transformed into BL21 (DE3) Escherichia coli. The recombinant E. coli was induced by 1 mmol/L IPTG to express BAG1 protein, which was purified by Ni-NTA column, and examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Six BALB/c mice were immunized subcutaneously with 20 μg purified BAG1 protein three times (Freunds complete adjuvant was used for the primary immunization, and the same amount of Freunds incomplete adjuvant was used for two boosting at an interval of two weeks). The mice with a high antibody titer were selected to collect spleen tissues for separating splenocytes, which were fused with SP2/0 myelomacells. The positive hybridoma cells were screened by indirect ELISA using purified BAG1 protein, and then underwent multiple subcloning screening for the hybridoma cell line presenting stable secretion of monoclonal antibody against BAG1. The supenant of the hybridoma cell line was collected, of which the antibody titer and sub-typing were determined by indirect ELISA. Four BALB/c mice were injected intraperitoneally with 0.5 ml liquid paraffin for one week, further intraperitoneal injection was delivered with 106 monoclonal hybridoma cells/mouse. The mice ascites was collected and the monoclonal antibody against BAG1 was purified by affinity chromatography. Lysed protein was prepared from the in vitro induced and in vivo formed ME49 toxoplasma, of which the BAG1 expression was examined by Western blotting using the purified anti-BAG1 monoclonal antibody as the first antibody, and the bradyzoite status was checked by indirect immunofluorescence assay (IFA). Results The open reading frame fragment of bag1 was obtained by RT-PCR, which was 690 bp, encoding 229 amino acids. The recombinant plasmid pET-28a(+)-bag1 was identified by PCR and subsequent sequencing. SDS-PAGE results showed that the relative molecular weight (Mr) of the recombinant BAG1 protein was about 27 000, which was expressed in the form of soluble protein and inclusion body. The results of indirect ELISA showed that the average titer of serum antibody could reach 1 ∶ 102 400 after immunizing mice with purified BAG1 protein for 3 times. Four positive monoclonal hybridoma cell lines were obtained by fusion screening, which were mAb1H03, mAb4B04, mAb5H07, and mAb8B12, respectively. mAb4B04 clone had the highest titer of 1 ∶ 25 600, and the antibody subtype was IgG1. Western blotting showed that the mAb4B04 antibody could detect the BAG1 protein of ME49 strain induced by the alkaline medium in vitro and the BAG1 protein of ME49 strain from mouse brain homogenate. IFA results showed that the mAb4B04 antibody could successfully detect ME49 bradyzoites induced by alkaline medium in vitro and in the BAG1 protein of ME49 strain in the mouse brain homogenate. Conclusion Monoclonal antibodies against T. gondii BAG1 were produced, among them the mAb4B04 antibody with the highest titer can specifically recognize BAG1 protein and bradyzoite of T. gondii ME49 strain.

Cite this article

ZOU Wei-hao , WU Wei-ling , LIAO Yuan-peng , CHEN Min , PENG Hong-juan . Preparation and application of monoclonal antibody against Toxoplasma gondii bradyzoite antigen 1[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022 , 40(5) : 587 -593 . DOI: 10.12140/j.issn.1000-7423.2022.05.004

References

[1] Dubey JP. The history of Toxoplasma gondii: the first 100 years[J]. J Eukaryot Microbiol, 2008, 55(6): 467-475.
[2] Coppin A,, Dzierszinski F,, Legrand S, et al. Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii[J]. Biochimie, 2003, 85(3/4): 353-361.
[3] Dubey JP,, Lindsay DS,, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts[J]. Clin Microbiol Rev, 1998, 11(2): 267-299.
[4] Alday PH,, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status[J]. Drug Des Dev Ther, 2017, 11: 273-293.
[5] Parmley SF,, Weiss LM,, Yang S. Cloning of a bradyzoite-specific gene of Toxoplasma gondii encoding a cytoplasmic antigen[J]. Mol Biochem Parasitol, 1995, 73(1/2): 253-257.
[6] Bohne W,, Gross U,, Ferguson DJ, et al. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants[J]. Mol Microbiol, 1995, 16(6): 1221-1230.
[7] Ma YF,, Zhang YW,, Kim K, et al. Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus[J]. Int J Parasitol, 2004, 34(3): 333-346.
[8] Li CJ,, Zhou TY,, Yu ZQ, et al. Effects of Toxoplasma gondii heat shock protein 21 on the function of mouse macrophage in vitro[J]. J Nanjing Agric Univ, 2021, 44(1): 136-143. (in Chinese)
[8] ( 李纯静,, 周天缘,, 于正青, 等. 刚地弓形虫热休克蛋白21体外条件下对小鼠巨噬细胞功能的影响[J]. 南京农业大学学报, 2021, 44(1): 136-143.)
[9] Mun HS,, Aosai F,, Yano A. Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/BAG1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii[J]. Microbiol Immunol, 1999, 43(5): 471-479.
[10] di Cristina M,, del Porto P,, Buffolano W, et al. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection[J]. Microbes Infect, 2004, 6(2): 164-171.
[11] Zhang YW,, Kim K,, Ma YF, et al. Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation[J]. Mol Microbiol, 1999, 31(2): 691-701.
[12] Yin Q. Construction of a Δbag1Δku80 strain and evaluation of its safety, immunogenicity and efficacy as a vaccine candidate against cat toxoplasmosis[D]. Beijing: China Agricultural University, 2015: 66-71. (in Chinese)
[12] ( 尹青. 弓形虫Δbag1Δku80株的构建及其作为猫弓形虫病疫苗候选株的免疫原性、安全性和效力的评价[D]. 北京: 中国农业大学, 2015: 66-71.)
[13] Ascoli CA,, Aggeler B. Overlooked benefits of using polyclonal antibodies[J]. Biotechniques, 2018, 65(3): 127-136.
[14] Posner J,, Barrington P,, Brier T, et al. Monoclonal antibodies: past, present and future[J]. Handb Exp Pharmacol, 2019, 260: 81-141.
[15] Wang P,, Lu GL,, Fan YJ, et al. Seroepidemiological survey of Toxoplasma gondii in dogs in Urumqi[J]. Chin J Parasitol Parasit Dis, 2014, 32(5): 404-405. (in Chinese)
[15] ( 汪萍,, 陆桂丽,, 范玉娟, 等. 乌鲁木齐市犬弓形虫血清流行病学调查与分析[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(5): 404-405.)
[16] Deng Y,, Wu T,, Zhai SQ, et al. Recent progress on anti-Toxoplasma drugs discovery: design, synthesis and screening[J]. Eur J Med Chem, 2019, 183: 111711.
[17] Yao N,, Gong JZ,, Fan YM, et al. Research progress on drugs for the treatment of toxoplasmosis[J]. China Animal Husb & Vet Med, 2020, 47(4): 1250-1257. (in Chinese)
[17] ( 姚娜,, 龚静芝,, 范益敏, 等. 弓形虫病治疗药物的研究进展[J]. 中国畜牧兽医, 2020, 47(4): 1250-1257.)
[18] Shao RG. Monoclonal antibody-based cancer immunotherapy[J]. Acta Pharm Sin, 2020, 55(6): 1110-1118. (in Chinese)
[18] ( 邵荣光. 基于单克隆抗体的肿瘤免疫治疗[J]. 药学学报, 2020, 55(6): 1110-1118.)
[19] Ding JQ,, Wu K,, Tan F, et al. Establishment of an in vitro tachyzoite-bradyzoite interconversion system for Toxoplasma gondii[J]. J South Med Univ, 2010, 30(4): 668-671. (in Chinese)
[19] ( 丁洁琼,, 吴焜,, 谭峰, 等. 弓形虫速殖子与缓殖子体外转化体系的建立[J]. 南方医科大学学报, 2010, 30(4): 668-671.)
[20] Tobin C,, Pollard A,, Knoll L. Toxoplasma gondii cyst wall formation in activated bone marrow-derived macrophages and bradyzoite conditions[J]. J Vis Exp, 2010(42): 2091.
Outlines

/

〈 〉